Thomas Watkins - 29 Sep 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
Director
Signature
/s/ Meghanne Downes, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
29 Sep 2023
Net transactions value
+$1,106,550
Form type
4
Filing time
02 Oct 2023, 19:32:08 UTC
Previous filing
28 Jul 2023
Next filing
06 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $491,600 +40,000 +137% $12.29 69,124 29 Sep 2023 Direct
transaction HZNP Ordinary Shares Options Exercise $319,200 +20,000 +29% $15.96 89,124 29 Sep 2023 Direct
transaction HZNP Ordinary Shares Options Exercise $295,750 +21,323 +24% $13.87 110,447 29 Sep 2023 Direct
holding HZNP Ordinary Shares 10,000 29 Sep 2023 By Family Limited Partnership
holding HZNP Ordinary Shares 55,953 29 Sep 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (right to buy) Options Exercise $0 -40,000 -100% $0.000000* 0 29 Sep 2023 Ordinary shares 40,000 $12.29 Direct F1
transaction HZNP Stock Option (right to buy) Options Exercise $0 -20,000 -100% $0.000000* 0 29 Sep 2023 Ordinary shares 20,000 $15.96 Direct F1
transaction HZNP Stock Option (right to buy) Options Exercise $0 -21,323 -66% $0.000000 10,838 29 Sep 2023 Ordinary shares 21,323 $13.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested.